Inhibitory control is not lateralized in Parkinson's patients.

Area of Science:

• Neuroscience
• Cognitive Psychology
• Neurology

Background:

• Parkinson's disease (PD) often presents with asymmetrical motor symptoms, reflecting lateralized brain hemisphere involvement.
• Asymmetric subcortical dopamine deficiencies in PD offer a unique model to study lateralized cognitive effects.
• Inhibitory control, a key executive function, is hypothesized to rely on right-hemisphere pathways.

Purpose of the Study:

• To investigate the impact of lateralized dopamine deficiency in Parkinson's disease on inhibitory control.
• To compare deficits in proactive and reactive inhibition between left-dominant PD (LPD) and right-dominant PD (RPD) patients.
• To test the hypothesis of right-hemisphere lateralization for inhibitory control in PD.

Main Methods:

• A countermanding task was employed to assess proactive and reactive inhibition.
• Participants included 20 LPD patients, 20 RPD patients, and 20 age-matched healthy controls.
• Performance on the inhibition tasks was compared across the three groups.

Main Results:

• Parkinson's disease patients exhibited significantly greater impairments in both proactive and reactive inhibition compared to healthy subjects.
• No significant differences in either proactive or reactive inhibition were found between LPD and RPD patients.
• These findings indicate that while PD affects inhibitory functions, the lateralization of symptoms does not differentially impact these abilities.

Conclusions:

• Brain regions affected by Parkinson's disease are crucial for inhibitory control.
• The study does not support a predominantly or solely right-hemisphere computation of inhibitory control in the context of PD.
• Lateralization of PD symptoms does not lead to differential deficits in proactive or reactive inhibition.